Or it's just not big enough news to cause a proper re-rate.
Azer-cell had already given us 39 CR's from 84 patients with various lymphoma indications.
While another 3 CR's, plus news of the improved treatment regime is great.. The announcement also tells us that they need to keep enrollment going for some time yet. They haven't said how many more, but enough to consider adding 5 new trial sites to the existing 15.
This means that it is likely that the timeline has been pushed out another 12 months.
New Vaxinia or onCARlytics data would excite me a lot more than todays news.
Or it's just not big enough news to cause a proper...
-
- There are more pages in this discussion • 573 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.002(3.13%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 5.0¢ | 4.8¢ | $351.9K | 7.209M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 2360562 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 5195401 | 29 |
View Market Depth
| Last trade - 13.28pm 07/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |